Dreavent 6

Dreavent 6 is a Cambridge, Massachusetts-based venture capital firm investing in biotechnology, life sciences and pharmaceuticals across the United States and Spain. Its Bio Asset Engineering model starts with confirmed pharmaceutical demand, works backward to identify science, and backs companies when a pharmaceutical partner has aligned on indication, biomarkers and clinical endpoints. The firm is relevant for founders in early- to later-stage biotech and pharmaceutical rounds, especially those connected to Boston’s biotech ecosystem or transatlantic Spain-Boston opportunities.